Mirae Asset Global Investments Co., Ltd. Harmony Biosciences Holdings, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $54.3 Billion
- Q1 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 12,952 shares of HRMY stock, worth $414,982. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,952
Previous 16,562
21.8%
Holding current value
$414,982
Previous $534,000
18.73%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding HRMY
# of Institutions
215Shares Held
44MCall Options Held
68.4KPut Options Held
52.1K-
Valor Management LLC Chicago, IL11.2MShares$359 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.92MShares$190 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.63MShares$116 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$83.5 Million11.71% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.49MShares$79.9 Million0.22% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.9B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...